Drug · DIN 02414945
TIVICAY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 8, 2013; first marketed November 8, 2013.
- Drug Identification Number (DIN)
- 02414945
- Company (DIN owner)
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Dolutegravir J05AJ03
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 31, 2013: NOC 14913New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “tivicay”. A notice may cover another product or only some lots: read it to see what it covers.
- TIVICAY, TRIUMEQ and JULUCA (dolutegravir containing medicines) – Possible Risk of Neural Tube DefectsJune 7, 2018 · Drugs · Product safety
Other DINs named TIVICAY
- DIN 02511517 · Marketed
- DIN 02461218 · Cancelled Post Market
- DIN 02461226 · Cancelled Post Market